TriMix is a compounded medication that is used to treat erectile dysfunction. It is a mixture of papaverine, phentolamine, and alprostadil, which act as vasodilators. This means they widen blood vessels to allow more blood flow to the penis.
The inability to achieve or maintain penile erection long enough for sexual activity. This condition affects men primarily between the ages of 40 and 70.
About 20 million men in the United States suffer from this condition, and this number is projected to increase to greater than 300 million by the year 2025[1]
The standard first-line treatment for this condition is oral phosphodiesterase type 5 (PDE5) inhibitors such as Sildenafil and Tadalafil; these work by relaxing of the corpus cavernosum inside the penis and consequently, penile erection [2]
Some individuals, however, who may not tolerate PDE5 inhibitors for any reason are poorly responsive to this class of medications. An alternative option that has been used with promising results in the management and treatment of ED is TriMix. TriMix is a second-line medication used to treat ED in men for whom PDE5 inhibitors are not an acceptable option.
TriMix ED injections contain a mixture of three drugs: phentolamine, papaverine and alprostadil.
This drug is not readily available in traditional retail pharmacies but must be specially made at compounding pharmacies like SandsRx. The components of TriMix work synergistically causing sustained penile erections in individuals suffering from ED.
In contrast to the first-line drug treatment of ED, PDE5 inhibitors, which are administered orally, TriMix ED treatment is an injectable medication that is administered locally into the penis.
This medication is typically compounded at dosages that are tailored to the requirements of everyone.
Injecting Trimix into the corpus cavernosum, results in the relaxation, expansion, and filling of the corpus cavernosum with blood. This may result in penile erections that last throughout the duration of sexual intercourse.[3]
There are two primary reasons that men with ED may consider using TriMix ED injections:
Do not take this medicine with any of the following Conditions:
Store refrigerated or frozen as directed, protect from light. Keep all medicine out of the reach of children. Throw away any unused medicine after the beyond use date. Do not flush unused medications or pour down a sink or drain.
Some men may feel anxious or squeamish about self-injecting themselves, this is a relatively painless procedure if done properly with correct technique. Discussed below are the steps that are needed to safely self-administer the TriMix injection [5][6]
The effects of TriMix ED injections become evident about 5 – 15 minutes after its injection into the penis as it induces a penile erection. Its duration action typically varies depending on the individual, ranging anywhere between half an hour to an hour. However, its effects should not last longer than 3 hours. The prescribing physician should be consulted immediately if the erection becomes prolonged.
TriMix is an innovative treatment for erectile dysfunction that offers a safe, effective alternative to traditional ED treatments. SandsRx compounding pharmacy is proud to offer TriMix injections as an effective treatment option for our patients, and we can ensure personalized care from start to finish. We specialize in urology compounding and men’s health, and we have three locations in Wylie, Frisco, and McKinney, TX and we are very proud to be a trusted compounding pharmacy near Dallas and Fort Worth, TX. Contact us to begin the treatment process today.
Montague DK, Jarow JP, Broderick GA, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol 2005;174:230-9.
Leungwattanakij S, Flynn V, Hellstrom WJG. Intracavernosal injection and intraurethral therapy for erectile dysfunction. Urol Clin North Am 2001;28:343-354.
Delcour, C., et al., The effect of papaverine on arterial and venous hemodynamics of erection. J Urol, 1987. 138(1): p. 187-9.
Mooradian, A.D., et al., Biweekly intracavernous administration of papaverine for erectile dysfunction. West J Med, 1989. 151(5): p. 515-7.
Dinsmore, W.W., Medical treatment of impotence with papaverine and phentolamine intracavernosal injection. Ulster Med J, 1990. 59(2): p. 174-6.
Keogh, E.J., et al., Treatment of impotence by intrapenile injections of papaverine and phenoxybenzamine: a double blind, controlled trial. Aust N Z J Med, 1989. 19(2): p. 108-12.
Kirkeby, H.J., et al., [Infusion cavernosography and erectile dysfunction]. Ugeskr Laeger, 1990. 152(24): p. 1724-6.